INS and metabolic syndrome: For example, the beneficial role of n3 PUFAs has been postulated for the prevention of metabolic syndrome or T2DM, but there is no conclusive evidence, and some studies have shown a lack of significant effect of n3 PUFA on glycemic control or insulin sensitivity [28, 29].